Articles by : Shannon Young, Associate Editor/Senior Writer

Study Finds Oncology Markups at 340B Pediatric Hospitals; AHA Slams Study and Funder

July 16, 2024 Views

New research looked at the prices 340B-enrolled pediatric hospitals charged for pediatric oncology drugs.

The rates 340B pediatric hospitals negotiate with payers for new pediatric oncology drugs often exceed a medication’s average sale price, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Matsui’s 340B PATIENTS Act Gains 5 Democratic Co-Sponsors Ahead of 340B Health Lobby Days

July 11, 2024 Views

Five congressional Democrats signed on as co-sponsors to a bill that would bar drugmaker restrictions on 340B contract pharmacy arrangements.

As hospital advocates prepared to begin their annual summer visits to Capitol Hill this week, five congressional Democrats signed on [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Drug Industry Takes Issue with IRA’s Drug Negotiation Guidance

July 11, 2024 Views

PhRMA recently urged CMS to establish a neutral clearinghouse and require accurate use of 340B claim modifiers to address nonduplication in its final guidance for Medicare drug price negotiations under the IRA.

Editor’s Note: In Tuesday’s issue, we looked at comments from 340B provider stakeholders, today we look more closely at the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Apotex to Issue Refunds to 340B Covered Entities

July 11, 2024 Views

Apotex Corp. announced in a July 2 notice to 340B providers that it will issue refunds to 340B covered entities that purchased any of nearly 400 products.

A Canadian drug manufacturer recently announced that it will refund covered entities for hundreds of different products purchased between 2021 [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

340B Providers Take Issue with CMS Draft Guidance on IRA Implementation Calling It “Problematic, Unworkable and Inconsistent”

July 9, 2024 Views

340B provider groups strongly criticized the Centers for Medicare & Medicaid Services’ draft guidance for Medicare drug price negotiations.

Editor’s Note: In today’s issue, we look at the 340B provider community’s comments to CMS. In a future issue, we [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Astellas Suspends its Contract Pharmacy Restrictions in More States; BMS and Sanofi Also Announce State Exemptions

July 9, 2024 Views

Astellas Pharma announced the suspension of its contract pharmacy policy in Maryland and Mississippi.

A Japanese drug manufacturer has ended its 340B contract pharmacy restrictions in Maryland and Mississippi in conjunction with new contract [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

AbbVie, AstraZeneca Sue Minnesota Over Contract Pharmacy Access Law

July 9, 2024 Views

AbbVie and AstraZeneca filed a pair of lawsuits to block Minnesota's law barring manufacturer 340B contract pharmacy restrictions.

Two major drug manufacturers are suing Minnesota to block a new 340B contract pharmacy access law, which took effect this [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

AbbVie, AstraZeneca Challenge Kansas’ New Contract Pharmacy Access Law

July 5, 2024 Views

AbbVie will no longer offer voluntary 340B pricing on any of its orphan-designated drugs to covered entities subject to such exclusions.

Two major drug manufacturers this week sued Kansas in an effort to block the state’s new contract pharmacy access law, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Hospital Groups Urge Federal Court to Uphold Maryland’s 340B Contract Pharmacy Access Law

July 2, 2024 Views

The American Hospital Association (AHA), 340B Health, Maryland Hospital Association and Mid-Atlantic Association of Community Health Centers urged a federal judge to reject Novartis’ attempt to block Maryland’s new 340B contract pharmacy access law.

Groups representing Maryland providers along with national advocacy groups recently urged a federal judge to reject Novartis’ attempt to block [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Hospitals in Texas and Other States Sue HHS Over DSH Calculation Changes That Impact 340B Eligibility

July 2, 2024 Views

Dozens of hospitals in Texas and other states have filed suit against HHS to block a rule that they say lowers their disproportionate share hospital adjustment percentage and could result in a loss of 340B discounts.

Dozens of hospitals in Texas and other states have filed suits against Department of Health and Human Services (HHS) Secretary [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

News Alert

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Site Footer Live